| Literature DB >> 32130912 |
Raya Faigenbaum-Romm1, Avichai Reich1, Yair E Gatt1, Meshi Barsheshet1, Liron Argaman1, Hanah Margalit2.
Abstract
Bacterial small RNAs (sRNAs) are posttranscriptional regulators of gene expression that base pair with complementary sequences on target mRNAs, often in association with the chaperone Hfq. Here, using experimentally identified sRNA-target pairs, along with gene expression measurements, we assess basic principles of regulation by sRNAs. We show that the sRNA sequence dictates the target repertoire, as point mutations in the sRNA shift the target set correspondingly. We distinguish two subsets of targets: targets showing changes in expression levels under overexpression of their sRNA regulator and unaffected targets that interact more sporadically with the sRNA. These differences among targets are associated with their Hfq occupancy, rather than with the sRNA-target base-pairing potential. Our results suggest that competition among targets over Hfq binding plays a major role in the regulatory outcome, possibly awarding targets with higher Hfq binding efficiency an advantage in the competition over binding to the sRNA.Entities:
Keywords: Hfq; RIL-seq; RNA sequencing; posttranscriptional regulation; small RNAs
Mesh:
Substances:
Year: 2020 PMID: 32130912 PMCID: PMC7059120 DOI: 10.1016/j.celrep.2020.02.016
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1Schematic Description of the Study and Generated Data
RNA-seq experiments were performed on samples with and without sRNA overexpression. Differential expression analysis was conducted, and the results were intersected with RIL-seq interactions of the studied sRNA under the same growth condition as in the RNA-seq experiment (Melamed et al., 2016). Four subsets of genes could be discerned: two with an expected regulatory outcome (I and IV, marked in green) and two with an unexpected outcome (II and III, marked in pink). See also Figure S4 and Tables S1, S2, S3, and S4.
Figure 2Measuring the Effect of the sRNA on Target mRNA Levels
(A) Only a subset of the targets shows an expression change following sRNA overexpression. Shown are Volcano plots of RNA-seq results of gene expression change following sRNA overexpression. Gene expression change is represented by the log2 fold change in expression levels, as obtained from DESeq2 analysis (Love et al., 2014) (x axis). The statistical significance of the change is represented as −log10p (y axis). p is the p value corrected for multiple hypothesis testing (padj from DESeq2). For clarity, only genes with −log10p ≤ 20 are presented. Green dots represent the sRNA targets that were detected by RIL-seq applied to E. coli grown to a certain growth phase or condition (GcvB to exponential phase; MicA, ArcZ, and CyaR to stationary phase; and RyhB to exponential phase under iron limitation). Black dots represent the rest of the E. coli genes. The dashed line represents the statistical significance threshold (p ≤ 0.1).
(B) sRNA targets detected by RIL-seq were enriched among genes showing a statistically significant change in expression level following overexpression of the sRNA (statistical significance of the enrichment was computed by hypergeometric test). Black numbers represent non-target genes showing a statistically significant change in expression (both up- and downregulated). Blue/green numbers represent RIL-seq targets that showed/did not show a statistically significant change in expression.
See also Figures S1, S3, and S4, and Tables S1, S2, S3, and S4.
Figure 3The sRNA Binding Site Dictates the Target Repertoire
Common motifs identified in the sequences of RIL-seq targets of ArcZ WT, ArcZ with single mutation C71G (ArcZ M1), or ArcZ with three mutations C71T T72G G73A (ArcZ M2). For each version of ArcZ, the identified common motif is complementary to the corresponding sRNA binding site sequence. The ArcZ WT sequence is shown in black, and the mutations are in orange. The motifs and E values were determined by MEME (Bailey et al., 2009). See also Figure S2 and Table S5.
Figure 4Both Affected and Unaffected Targets Contain a Complementary Sequence to the Binding Site of Their Interacting sRNA
A bar plot representing the percentages of affected and unaffected targets containing complementary sequences to the binding site of the respective sRNA (Melamed et al., 2016). High percentages of targets with complementary binding sites were observed for both subsets of targets. Blue and orange bars represent the affected and unaffected targets, respectively. See also Tables S3 and S4.
Figure 5The Interactions of the sRNA with Affected Targets Are Reproducibly Detected and Are More Abundant Than the Interactions with Unaffected Targets
(A) Interactions with affected targets were identified in more replicate experiments than interactions with unaffected targets. A zero number of replicates represents interactions that were identified only in a unified library (i.e., unifying the results from all replicate experiments) (Melamed et al., 2016). The RIL-seq experiment included six, three, and three replicates for the exponential phase, stationary phase, and exponential phase under iron limitation, respectively. The RNA-seq experiment of GcvB was performed in the exponential phase; those of MicA, ArcZ, and CyaR were performed in the stationary phase; and that of RyhB was performed in the exponential phase under iron limitation.
(B) Affected targets establish more interactions with the sRNA than do unaffected targets, as represented by the number of chimeric fragments (log10).
Blue and orange colors represent the affected and unaffected targets, respectively. For each sRNA, n1 and n2 are the numbers of affected and unaffected targets, respectively. Statistical significance was assessed by Wilcoxon rank-sum test. See also Tables S3 and S4.
Figure 6The Hfq Occupancy of Targets Correlates with Their Interaction Frequency
(A) The predicted binding free energy of the duplex between the target and the sRNA is only weakly correlated with the sRNA-target interaction frequency (represented by the number of chimeric fragments). Binding free energy values (in kilocalories per mole) between two interacting RNAs were computed by RNAup (Mückstein et al., 2006). Spearman correlations coefficients are presented (p < 10−6 to p < 0.8).
(B) The target’s Hfq occupancy is highly correlated with the sRNA-target interaction frequency. Presented is the correlation between the Hfq-target abundance (targetHfq, number of sequenced fragments representing the target abundance on Hfq) and the number of chimeric fragments. Numbers of sequenced fragments are presented by log10. Spearman correlation coefficients are presented (p < 10−51 to p < 10−16).
Blue and orange dots represent the affected and unaffected targets, respectively. See also Tables S3 and S4.
Figure 7The Binding Efficiency of a Target Transcript to Hfq Affects Its Regulatory Fate
Competition between targets over binding to Hfq is a major determinant of the regulatory fate of the targets. Left panel: a target that binds Hfq efficiently will compete successfully with other targets over binding to Hfq, resulting in more interactions with the sRNA and a change in expression. Right panel: a target that is an inefficient Hfq binder will not succeed in competing with other targets over binding to Hfq, resulting in a low number of sRNA-target interactions and no effect on the expression level of the target. Green circles represent Hfq monomers. Green, blue, and orange waved lines represent a target RNA, an affected target RNA, and an unaffected target RNA, respectively. The sRNA is depicted in purple.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| General lab strain | MG1655 | |
| Received from S. Altuvia laboratory | MG1655 lacIq | |
| Expressys | N/A | |
| Current work | N/A | |
| Current work | Δ | |
| Current work | Δ | |
| Current work | Δ | |
| Current work | Δ | |
| Current work | MG1655 Δ | |
| The Keio collection, | BW25113 | |
| The Keio collection, | BW25113 Δ | |
| Invitrogen | TOP10 | |
| Current work | Δ | |
| 0.1 mm Glass Beads | BioSpec | Cat #:110079101 |
| Anti-Flag M2 Monoclonal Antibody | Sigma | Cat #: F1804; RRID: |
| RNase A/T1 mix | ThermoFischer Scientific | Cat #: EN0551 |
| T4 Polynucleotide Kinase | New England Biolabs | Cat #: M0236L |
| T4 RNA ligase 1, High Concentration | New England Biolabs | Cat #: M0437M |
| RNAClean XP | Beckman Coulter | Cat #: A63987 |
| AMPure XP | Beckman Coulter | Cat #: A63881 |
| Recombinant RNase inhibitor | Takara | Cat #: 2313A |
| TURBO DNase | ThermoFischer Scientific | Cat #: AM2238 |
| FastAP | ThermoFischer Scientific | Cat #: EF0654 |
| RLT buffer | QIAGEN | Cat #: 79216 |
| Glycoblue | ThermoFischer Scientific | Cat #: AM9516 |
| TriReagent | Sigma-Aldrich | Cat #: T9424 |
| Ultra-pure water, RNase- and DNase-free | Biological Industries | Cat #: 01-866-1A |
| Acrylamide/Bis-Acrylamide 19:1 40% | Bio-Lab | Cat #: 000135233500 |
| 37% Formaldehyde | J.T. Baker | Cat #: 7040.1000 |
| RiboRuler High Range RNA ladder | ThermoFischer Scientific | Cat #: SM1821 |
| pUC18/MspI Marker | ThermoFischer Scientific | Cat #: SM0221 |
| Zeta-Probe Blotting Membranes | Bio-Rad | Cat #: 162-0159 |
| Mini Protean TGX 4-20% gels | Bio-Rad | Cat #: 4568095 |
| Trans-Blot Turbo Transfer Pack | Bio-Rad | Cat #: 1704159 |
| QuikChange Lightning Site-Directed Mutagenesis Kit | Agilent | Cat #: 210519 |
| RiboZero kit for bacteria | Illumina | Cat #: MRZGN126 |
| SuperScript III first strand kit | Invitrogen | Cat #: 18080-051 |
| HIFI HotStart RM | Kapa Biosystems | Cat #: KK2601 |
| Qubit dsDNA HS Assay kit | Invitrogen | Cat #: Q32854 |
| High sensitivity D1000 ScreenTape | Agilent Technologies | Cat #: 5067-5584 |
| High sensitivity D1000 reagents | Agilent Technologies | Cat #: 5067-5585 |
| Bioanalyzer RNA 6000 Nano kit | Agilent Technologies | Cat #: 5067-1511 |
| Bioanalyzer RNA 6000 Pico kit | Agilent Technologies | Cat #: 5067-1513 |
| RNA clean and Concentrator™-5 kit | Zymo Research | Cat #: R1016 |
| ArcZ comparative RIL-seq | Current work | E-MTAB-8224 |
| Total expression libraries of GcvB, MicA, ArcZ WT, ArcZ M1, ArcZ M2, RyhB and CyaR overexpression | Current work | E-MTAB-8229 |
| Strain construction oligos | N/A | |
| Plasmid construction and mutagenesis oligos | N/A | |
| Library preparation oligos | N/A | |
| Northern blots probes | N/A | |
| pZE12-luc; AmpR ; PLlacO-1 | Expressys | N/A |
| pMicA; AmpR ; PLlacO-1 | N/A | |
| pBRplac; AmpR ; PLlacO-1 | N/A | |
| pEF21; CmR; PBAD | Received from S. Altuvia lab | N/A |
| pEF21-Hfq; CmR; PBAD | Current work | N/A |
| pZE12-ArcZ; AmpR ; PLlacO-1 | Current work | N/A |
| pZE12-ArcZ M1; AmpR ; PLlacO-1 | Current work | N/A |
| pZE12-ArcZ M2; AmpR ; PLlacO-1 | Current work | N/A |
| pZE12-CyaR; AmpR ; PLlacO-1 | Current work | N/A |
| pJV300; AmpR ; PLlacO-1 | N/A | |
| pTP-011; AmpR ; PLlacO-1 | N/A | |
| pZA12-GcvB (pJU-014) ; AmpR ; PLlacO-1 | N/A | |
| pXG10-SF; CmR; PLtetO-1 | N/A | |
| pXG-0; CmR; PLtetO-1 | N/A | |
| pXG10-SF-raiA; CmR; PLtetO-1 | Current work | N/A |
| pZE12-RaiZ; AmpR ; PLlacO-1 | Current work | N/A |
| pZE12- | Current work | N/A |
| pXG10-SF-gatY; CmR; PLtetO-1 | Current work | N/A |
| pXG10-SF-lpp; CmR; PLtetO-1 | Current work | N/A |
| DESeq2 | ||
| RNAup | ViennaRNA package, the University of Vienna | |
| RNAduplex | ViennaRNA package, the University of Vienna | |
| MEME | ||
| R | The R foundation | |
| R/ppcor package | ||
| Python | The Python Software Foundation | |
| Python/Biopython | ||
| Blastn | National Center for Biotechnology Information | |
| MUSCLE | ||
| Conservation profiler script | Current work | |
| RNAfold | ViennaRNA package, the University of Vienna | |
| Python RILseq package | ||